Gene and cellular therapy: gc-01

GC-01. Anti-CD19 CAR T-cell therapy in Belarus: Current state

Elena S. Lukojko¹, Alexandr A. Migas¹, Tatsiana V. Shman¹, Igor N. Severin², Olga A. Kalenik², Natalya N. Konoplia², Inna V. Proleskovskaya¹, Olga V. Aleinikova³

GC-02. Resistance to anti-CD19 CAR T-cell therapy. Case report

Alexandr A. Migas¹, Tatsiana V. Shman¹, Anna V. Klych¹, Elena S. Lukojko¹, Evgeniy V. Dmitriev¹, Lyudmila V. Movchan¹, Mikalai A. Katsin³, Inna V. Proleskovskaya¹, Olga V. Aleinikova²

GC-03. Lentiviral transduction efficiency of natural killer cells

Anastasia S. Mukhametshyna, Alexander A. Migas, Tatsiana V. Shman

GC-04. Studies on therapeutic potential of a radiopharmaceutical based on polymer capsules with incorporated 188Re isotope for the treatment of inflammatory joint diseases

Alisa S. Postovalova^1,2, Timofey E. Karpov^1,2, Nikolay A. Kostenikov², Dmitry S. Sysoev², Dmitry O. Antuganov², Darya R. Akhmetova^1,2, Albert R. Muslimov¹, Alexander S. Timin^1,2

GC-05. Improving the efficiency of long targeted insertions into the human cell genome using the TALEN editing platform and non-viral delivery techniques for gene therapy of socially significant diseases

Alena I. Shakirova, Timofei E. Karpov, Yaroslava V. Komarova, Olga S. Epifanovskaya, Vladislav S. Sergeev, Marina O. Popova, Kirill V. Lepik, Alexander D. Kulagin

GC-06. In silico study of mutagenic effect of NCSTN gene in development of bone marrow neoplasms

Bogdan O. Shcheglov

GC-07. Production of injectable implant mesenchymal stem cells for treatment of osteoarthritis

Hanna A. Zhernasechanka¹, Yanina I. Isaikina¹, Dzmitry V. Bukach²

Gene and cellular therapy: GC-01 – GC-07